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Resolution of synaptic vesicle neurotransmitter content has mostly been limited to the study of stimulated
release in cultured cell systems, and it has been controversial as to whether synaptic vesicle transmitter levels
are saturated in vivo.We use electrochemical cytometry to count dopaminemolecules in individual synaptic
vesicles in populations directly sampled from brain tissue. Vesicles from the striatum yield an average of
33,000 dopamine molecules per vesicle, an amount considerably greater than typically measured during
quantal release at cultured neurons. Vesicular content was markedly increased by L-DOPA or decreased by
reserpine in a time-dependent manner in response to in vivo administration of drugs known to alter
dopamine release. We investigated the effects of the psychostimulant amphetamine on vesicle content,
finding that vesicular transmitter is rapidly depleted by 50% following in vivo administration, supporting
the ‘‘weak base hypothesis’’ that amphetamine reduces synaptic vesicle transmitter and quantal size.
S
ynaptic vesicles are the primary intracellular organelles responsible for the storage and release of chemical
messengers from neurons and other secretory cells. As such, they are key determinates in regulating
synaptic signaling. Extrapolating data from a 2004 paper by Sulzer and coworkers, repeated complex
flickering events measured at cultured midbrain neurons that mammalian vesicular content might be consid-
erably higher than previously thought with approximately 30,000 molecules released1. We recently developed a
novel method, electrochemical cytometry2, whereby the total transmitter content of individual nanoscale vesicles
can be quantified in a high throughput manner enabling the study of statistically relevant populations of vesicles.
In cultured pheochromocytoma (PC12) cells, an immortalized adrenal cell line, we compared large dense core
vesicle content with the amount of transmitter detected at individual release events and found that, at most, only
40% of vesicular transmitter is released during exocytosis3, which would be consistent with transient large dense
core vesicle fusion. Whether transient fusion with neurotransmission might occur with brain synaptic vesicles,
however, has remained a contentious issue.
Here, we use electrochemical cytometry to count dopamine neurotransmitter molecules in individual mouse
brain synaptic vesicles before and after pharmacological challenges. We find that the dopamine is present at
average levels of 33,000 molecules per vesicle, an order of magnitude greater than often estimated by previous
methods, which have relied primarily on measuring neurotransmitter release4–7. In vesicles isolated from mouse
brain tissue, we show that the number of dopamine molecules per striatal vesicle are significantly reduced
following in vivo administration of reserpine, a prodepressant and high blood pressure medication that inhibits
vesicular monoamine neurotransmitter uptake. By contrast, dopamine vesicular content increases after peri-
pheral administration of L-DOPA, the dopaminergic precursor widely used to treat Parkinson’s disease. Effects of
both drugs are time dependent, enabling in vivo pharmacokinetics with single vesicle resolution. The contrast
between estimates of quantal size based on release and the present results, as well as the drug-induced variations in
vesicle content, suggest that transmitter release during exocytosis might be regulated at the level of single release
events. This has implications for understanding synaptic plasticity and highlights vesicular neurotransmitter
levels as an important pharmaceutical target. In fact, the importance of this technique to study the effects of drugs
and animal models should be immense. In Parkinson’s disease for example, data are all based on release and there
are not any direct data related to actual vesicle content.
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Results
Counting transmitter molecules in individual vesicles. Electro-
chemical cytometry of neuronal vesicles was performed in a high-
throughput manner quantifying transmitter molecules in thousands
of individual vesicles per experiment. Although exocytosis is quantal
such that a discrete amount of transmitter is associated with each
vesicle, the number of molecules per vesicle is distributed across a
broad range. Vesicles were isolated from mice striatal tissue and
dopamine content was quantitatively investigated. Vesicle suspen-
sions were separated with capillary electrophoresis2,3,8,9, followed by
lysing of individual vesicles to expel their contents at a carbon-fiber
electrode enclosed in a microchannel (Figure 1A). We have pre-
viously shown that nearly all the electroactive transmitter in a
vesicle is oxidized at the electrode surface2. Oxidation of dopamine
results in an increase in current at the electrode (Figure 1B). The area
under each current spike represents the total amount of transmitter
per vesicle, which is quantified using Faraday’s law (N 5 Q/nF).
Here, N is the total number of moles of transmitter oxidized, Q is
equal to the total charge during oxidation, n is number of electrons
transferred during oxidation, and F is the Faraday constant. We
integrated the current-time transients for individual vesicles
obtained from mouse striatal tissue and plotted the number of
vesicles versus the amount of transmitter contained in each vesicle
(binned into groups) to produce histograms (Figure 1C). The
amount of transmitter in each vesicle is proportional to the vesicle
volume and here, vesicle radii are nearly normally distributed10.
Therefore, data are plotted as transmitter amount in zeptomoles to
the one-third power, providing nearly Gaussian plots for analysis.
Measurement of the content of mammalian synaptic vesicles
requires sub-picoampere sensitivity and precision (Figure 1B). The
species oxidized at the electrode is predominantly dopamine, since it
is the prevalent electroactive neurotransmitter in striatum, as con-
firmed by voltammetric release experiments in rats11,12 and HPLC
analyses of striatal tissue5,13. Integration of the current and relation
using Faraday’s Law yields an average mole amount of 55 6
0.4 zmol/vesicle (N 5 20,331 vesicles from 3 isolation experiments).
This corresponds to 33,000 6 300 dopamine molecules per vesicle.
Themean of the distribution in the frequency histogram in Figure 1C
is 3.7 zmol1/3, r2 5 0.99 for a single Gaussian fit. Additionally, in the
overall isolation experiments, the dopamine count per vesicle was
reproducible with 33,000, 34,000 and 33,000 molecules for isolation
1, 2, and 3, respectively.
The supernatant from isolated vesicle suspensions was re-centri-
fuged for an additional 3 h and the remaining vesicles were analyzed
to verify that the analysis included smaller vesicles that might take
longer to capture by centrifugation. Vesicles from this second isola-
tion contained an average of 30,000 dopamine molecules, not sig-
nificantly different from those quantified in the first isolation.
Electrochemical cytometry provides markedly low limits of trans-
mitter detection. A current transient that is representative of the
smaller subset of vesicles is shown on the right side of Figure 1B.
Integration of this peak yields 0.58 fC, which is equivalent to 3 zmol
or 1,800 dopamine molecules. This is comparable to the smallest
amounts quantified for vesicular dopamine content at small synaptic
vesicles (SSVs) using electroanalytical methods1.
Manipulating dopamine content in neuronal vesicles. Electro-
chemical cytometry was used to quantify changes in the numbers
of dopamine molecules in individual vesicles in response to drugs
that modify dopamine neurotransmission at different times after
parenteral administration. Figure 2A shows a representative cur-
rent transient for dopaminergic striatal vesicles isolated from mice
treated with 20 mg/kg reserpine 12 h prior to sacrifice. Reserpine
inhibits the transport of dopamine into synaptic vesicles via vesicular
monoamine transporters. A separate group ofmicewas administered
50 mg/kg L-DOPA and sacrificed 2 h later. L-DOPA is the
endogenous dopamine precursor and is used as standard treatment
in Parkinson’s disease. Data are compared to a representative current
spike from an untreated mouse.
The numbers of vesicular dopamine molecules following drug
administration were calculated using Faraday’s law, binned, and
Figure 1 | Electrochemical cytometry of mouse striatal vesicles
(A) Schematic of electrochemical cytometry. Electrochemical cytometry
uses capillary electrophoresis to separate individual neurotransmitter
vesicles. The electrophoresis capillary terminates into a PDMS-based
microfluidic device where individual vesicles undergo chemical lysis as
they exit and strike the carbon-fiber detection electrode. The vesicle
contents are quantitatively detected using amperometry.
(B) Representative data from electrochemical cytometry analysis of mouse
synaptic vesicles isolated from striatum. Presented is a 1000-s portion of an
electropherogram showing lysis and subsequent electrochemical detection
of total neurotransmitter content in synaptic vesicles. The inset depicts an
expanded axis to view the typical peak characteristics. To the right is shown
an event representative of the smallest vesicles quantified on the
electrochemical cytometry device. The peak integral is equal to 0.58 fC
(1,841 molecules, 3 zmol), and falls in line as one of the smaller vesicular
neurotransmitter amounts quantified by amperometry. (C) Normalized
frequency histogram for vesicular neurotransmitter amounts quantified
frommouse striatal vesicles by electrochemical cytometry. Data are plotted
as the cube root transform. Bin size 5 0.2 zmol1/3. Fit was obtained from a
Gaussian distribution of the data. Distribution mean is 3.7 zmol1/3. The
correlation coefficient for a single Gaussian fit of these data is 0.99.
www.nature.com/scientificreports
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plotted as normalized frequency histograms of cube root transforms.
The distribution for vesicles from reserpine-treated mice, as seen in
Figure 2B (red), is shifted to the left of control (black). The distri-
bution for L-DOPA treatment (blue) is shifted to the right of control
on the amount axis. The means of each distribution from single
Gaussian fits of the data were 2.9 zmol1/3, 3.7 zmol1/3, and 4.7 zmol1/3
for reserpine-treated, untreated, and L-DOPA-treated mice, respect-
ively. Reserpine lowered the average number of dopamine molecules
in striatal vesicles to 18,000, whereas L-DOPA resulted in an increase
in average vesicular dopamine to 71,000molecules (p, 0.001 versus
control).
The pharmacokinetics of treatments to alter vesicular dopamine
can be resolved at the level of single striatal vesicles. After it was
determined that changes in vesicular dopamine content could be
measured, temporally related changes in vesicular content were in-
vestigated using electrochemical cytometry. These data are summa-
rized in a cumulative statistical data analysis in Figure 2C. Mice were
injected with reserpine or L-DOPA and sacrificed at shorter inter-
vals following dosing. The mean number of dopamine molecules per
vesicle 6 h after reserpine was 29,000 6 400. This represents a 12%
decrease in transmitter compared to a 45% decrease at 12 h post-
treatment. An earlier time point after treatment was also investigated
for L-DOPA. Here, 51,000 6 200 dopamine molecules were present
in vesicles isolated from mouse striata 0.5 h after treatment. This re-
presents a 50% increase in transmitter compared to a 115% increase
2 h after L-DOPA administration.
Effects of amphetamine on vesicle content.Mice were administered
10 mg/kg (1)-amphetamine 1 h prior to isolating striatal vesicles for
analysis of dopamine content (Figure 3). Amphetamine-treatedmice
showed lower average vesicular dopamine content of 28 6 0.1 zmol
or 17,000 6 100 molecules per vesicle (p , 0.001 versus control).
Discussion
The advent of amperometric recordings of synaptic vesicular content
has indicated that quantal size can be modulated in neuronal culture
systems, for example by L-DOPA and amphetamine14–17. Never-
theless, it is possible that this type of modulation might not occur
in vivo, where synaptic vesicle content might be saturated. By adapt-
ing cytometry to synaptic vesicles directly isolated from brain tissue
following systemic drug treatment, we show that widely used med-
ications modulate synaptic vesicle transmitter content. These find-
ings increase understanding of the effects of these drugs in term of
their subcellular effects. They further suggest that control of synaptic
vesicle transmitter levels provides one avenue for synaptic plasticity.
Figure 2 | Pharmacological manipulation of striatal vesicle
neurotransmitter content (A) Representative current spikes for mice
receiving reserpine treatment (left, 12 h, 20 mg/kg), untreated (center), or
L-DOPA treatment (right, 2 h, 50 mg/kg). (B) Normalized frequency
histograms for reserpine-treated (red, 12 h, 20 mg/kg, distribution mean
5 2.9 zmol1/3) and L-DOPA-treated (blue, 2 h, 50 mg/kg, distribution
mean 5 4.7 zmol1/3) striatal vesicular dopamine content versus control
(black, 3.7 zmol1/3). Data are plotted as cube root transforms. Bin size 5
0.2 zmol1/3. Fits were obtained from a Gaussian distribution of the data.
(C) Cumulative analysis of striatal vesicles from mice with respect to drug
and time after treatment. The time after pharmacological treatment is
associated with regulation of neurotransmitter content in mouse synaptic
vesicles.Mean numbers ofmolecules of vesicular dopamine formice dosed
with 20 mg/kg reserpine for 12 h and 6 h treatments were 18,000 6 100
(N5 7,602) and 29,000 6 400 (N5 3,029) molecules, respectively. Mean
amount of vesicular dopamine from untreated mice striatal tissue was
33,000 6 100 (N 5 20,331) molecules. Mean numbers of molecules of
vesicular dopamine for mice dosed with 50 mg/kg reserpine for 0.5 h and
2 h were 51,000 6 200 (N 5 23,700) and 71,000 6 400 (N 5 22,047)
molecules, respectively. Mean values are significantly different from each
other (one-way ANOVA, p , 0.001).
Figure 3 | Effects of amphetamine on dopamine content of striatal
vesicles Mice were treated with (1)-amphetamine (10 mg/kg i.p.),
sacrificed after 1 h, and striata were dissected for vesicle isolation. Plotted
are normalized frequency histograms of vesicular data for amphetamine-
treated mice (blue) versus untreated mice (gray). The distribution means
were 2.9 zmol1/3 and 3.7 zmol1/3, for the amphetamine and untreated
vesicles, respectively. Data plotted as the cube root transform.
Bin size 5 0.2 zmol1/3. Fits were obtained from a Gaussian distribution of
the data.
www.nature.com/scientificreports
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Dopamine transmission pathways in the striatum are involved in
controlling a variety of behaviors including motor function, reward,
addiction, cognition, and are compromised in neurodegenerative
disorders, including Parkinson’s and Huntington’s disease18.
However, investigating vesicular content from CNS synapses is chal-
lenging owing to the small volume and content of these subcellular
organelles. Striatal synapses arising from ventral midbrain dopamine
neurons are mostly populated with electron-lucent small synaptic
vesicles (SSVs), which have been estimated by electron microscopy
to be,50 nm in diameter19, although occasional dense-core vesicles
have also been observed. Dopamine neurons have been reported to
possess small amounts of vesicular neurotransmitter, yielding 1000–
10,000 transmitter molecules per vesicle with an intravesicular con-
centration projected to be ,0.1 M10,20. These estimates have been
based primarily on extrapolations from experiments measuring
release from cells and tissues.
Here we use electrochemical cytometry to count molecules in
synaptic vesicles isolated directly from striatal brain tissue providing
content numbers that can be compared to in vitro electroanalytical
studies of exocytotic release performed at CNS dopaminergic neu-
rons1,5,6,21,22. Sulzer and co-workers investigated quantitative release
at single primary mouse midbrain neurons using amperometry and
recorded an average of 3,000 vesicular dopamine molecules released
via chemical stimulation of cells in culture5. Interestingly, five larger
release events with an average of 48,900 6 12,000 molecules were
quantified by amperometric measurements of neurons in culture but
were excluded from the analysis data set. It was later demonstrated
that vesicular release could be increased by overexpressing the vesi-
cular monoamine transporter (VMAT2) on vesicle membranes16.
Quantal size of released transmitter increased from an average of
7,800 molecules at control sites to 11,800 molecules at transfected
sites, and the frequency of exocytosis increased 10-fold. Chow and
co-workers performed amperometric measurements of dopaminer-
gic secretory vesicle quantal size using rat substantia nigra slices22. In
that study, exocytotic release was quantified in an environment that
more closely represents an in vivo experimental setting when com-
pared to primary cultures. However, in nigral slices, release was
somatodendritic rather than synaptic. Released dopamine measured
from the soma of nigral neurons yielded an average vesicle content of
14,000 molecules following chemical stimulation. Benzekhroufa
et al., also reported amperometric detection of serotonin release from
rat raphe tissue slices citing,28,000molecules from varicosities and
,34,000 molecules from cell bodies and in some cases as much as
800,000 molecules released23. These data further endorse the mea-
surements observed in the current study at midbrain neurons.
Interestingly, extrapolations from the amount of released dopamine
molecules per vesicle at synapses range from 10 to 40% when com-
pared to the electrochemical cytometry average (,33,000 mole-
cules), thus supporting the notion of partial vesicular release
during exocytosis3. This begs the question, is exocytotic release pre-
dominantly transient or ‘‘kiss and run’’ fusion?
Several experiments in the literature support the concept that in
exocytosis, what most consider full release is really partial. Using
quartz crystal microbalance gravimetry to examine exocytosis from
cell populations, we found that the large majority of release events
were immediately followed by endocytosis24. Looking at ‘‘complex’’
kiss and run events from mammalian cells, Sulzer and coworkers
suggested that the complex events represented consecutive rapid
transient fusion events from the same vesicle and each event was
reduced by an amount for which extrapolation would suggest a total
vesicular content of about 30,000 molecules1. Later, Borges and cow-
orkers showed in adrenal cells that patch amperometry of large dense
core vesicle exocytosis yielded approximately three times the release
amount compared to non-patched amperometry of similar cells25,
suggesting that the suction from the patch pipette pulls out the
remaining transmitter in an exocytosis event. Finally, Amatore and
coworkers have recently found that the fusion pore does not need to
open fully to accurately model the amperometric release transient
observed during exocytosis26. We have shown that only 40% of the
molecules in PC12 cell vesicles are released during amperometric
detection of exocytosis3 and evidence for vesicles closing again after
exocytosis27. If exocytotic release is not all or none, even in the full
exocytosis mode (in contrast to kiss and run release), then this pre-
sumes that release and transmission can be regulated at the level of a
single event by altering the released amount.
To manipulate vesicle count in vivo mice were treated with phar-
macological agents to alter vesicular neurotransmitter levels. The
dose used in the L-DOPA experiments is within the therapeutic dose
range and it causes a large increase in the number of dopamine
transmitter molecules in the average vesicle. Thus, synaptic vesicles
in vivo are not saturated with neurotransmitter, and considerable
plasticity is possible. This response might partially explain the clin-
ical action of L-DOPA, and is consistent with predictions made from
quantal recordings in cultured neurons. This result is also interesting
in light of the progression of Parkinson’s disease with the possibility
of oxidative stress increased by L-DOPA treatment versus its neuro-
protective potential28–31. Here, reserpine reduces vesicular content by
at least 45% (and perhaps more as the smallest content vesicles might
not be observed) and both of these drugs can be monitored for how
they affect vesicle content as a function of time. We note that a
smaller number of vesicles were measured from the electrochemical
cytometry of striatal tissue from reserpine-treated mice versus con-
trol and L-DOPA-treated groups (7,602 events versus ,20,000
events for control and L-DOPA groups). Perhaps some vesicles from
reserpine-treated mice fall below the detection threshold (33 RMS
noise). It is also possible that the smallest population of vesicles is lost
during the isolation procedures, although the results of experiments
involving additional centrifugation of supernatants do not support
this explanation. Alternately, reserpine might cause decreased num-
bers of vesicles available for release.
Amphetamine is a psychostimulant that has been reported to act
as a substrate for both VMAT2 and dopamine transporters32,33. An
action at synaptic vesicles has been proposed to occur by displace-
ment of dopamine from synaptic vesicles via a ‘‘weak base mech-
anism’’ that collapses the acidic vesicular pH gradient and/or
interactions with the vesicular transporter34. However, the hypo-
thesis that amphetamine affects synaptic vesicle transmitter stores
under pharmacologically relevant conditions remains controversial
and it has been reported that amphetamine does not, in fact, redis-
tribute dopamine from vesicles35. The mechanism of amphetamine
has also been investigated by performingmeasurements at PC12 cells
and at the dopaminergic nerve of Planorbis corneus32. Interestingly,
amphetamine was shown to cause an increase in extracellular dopa-
mine release from Planorbis, but a decrease in vesicular quantal size
(.50%) from PC12 cells. These data, in combination with whole cell
capillary electrophoresis measurements of cytosolic dopamine levels,
led to the hypothesis that amphetamine causes vesicles to redistribute
dopamine to the cytosol and supported the weak-base hypothesis.
Most experiments designed to investigate this mechanism have
involved model cell lines and in vitro systems. Here, we adapted
electrochemical cytometry to count dopamine molecules in mam-
malian vesicles directly after peripheral amphetamine treatment. The
number of dopamine molecules decreased by half at 1 h following a
moderate dose of amphetamine. Thus, we show evidence dem-
onstrating that vesicular dopamine can be depleted by this pharma-
cologically relevant dose and short exposure of amphetamine. This
could be due to redistribution of vesicular neurotransmitter to the
cytosol in accordance with the weak base hypothesis observed in the
in vitro analyses discussed a priori. Clearly this and other doses of this
drug will be interesting to study in the future.
These findings indicate that the number of dopamine molecules
per vesicle is considerably larger than anticipated based on prior
www.nature.com/scientificreports
SCIENTIFIC REPORTS | 3 : 1447 | DOI: 10.1038/srep01447 4
experiments using release measurements. This suggests that during
typical exocytosis, the full vesicle content is not released for trans-
mission and points to the possibility for regulation of the amount
released at the single vesicle level. Electrochemical cytometry pro-
vides a means to quantify transmitter molecules as a function of
individual vesicles in animal models of relevance for pharmaco-
logical studies and for studies of drugs of abuse. The concept of
partial vesicular release raises the possibility for new pharmaco-
logical targets at the vesicular level, and defines both the transmitter
count in a vesicle and the fraction released as having the potential to
be plastic. If this is a general phenomenon, it has implications for
short-term regulation where the number of transmitter molecules
and the kinetics of release might be modified from one event to
another.
Methods
Reagents.N-tris(hydroxymethyl)methyl-2-aminoethanesulfonic acid (TES), sodium
hydroxide (NaOH), sodium dodecyl sulfate (SDS), TrizmaH hydrochloride (Tris-
HCl), reserpine, and 3,4-dihydroxy-L-phenyl-alanine (L-DOPA), benserazide
hydrochloride, (1)-amphetamine, glacial acetic acid, hydrofluoric acid (HF, aq.
48%), sodium chloride (NaCl), potassium chloride (KCl), glucose, calcium chloride
(CaCl2), magnesium chloride (MgCl2), and Synaptic Vesicles Isolation Kits were
obtained from SigmaAldrich (St. Louis, MO). All chemicals were used as received. All
buffer constituents for isolation procedures are listed as proprietary knowledge of
Sigma Aldrich (e.g., homogenization, lysis, and storage buffers). The electrophoretic
separation buffer for electrochemical cytometry experiments consisted of 50 mM
TES with 2% 1-propanol. The lysis buffer for electrochemical cytometry was 50 mM
TES with 5% (w/v) SDS. All buffers were made in ultrapure water, adjusted to pH 7.4
using NaOH, and filtered through 0.2-mm pore size filters (Nalgene, Rochester, NY).
Animals and treatments. Male and female Crl:CD-1(ICR)BR mice were obtained
from Charles River Laboratories (Wilmington, MA) and bred in-house for 2–4
generations. Mice were 2- to 5-months old (average age 3 months) when they were
used for these experiments. Animals were group housed by sex (2–4mice per cage) in
a temperature and humidity controlled room on an automatic 12-h light/dark cycle.
Food and water were available ad libitum. Experimental protocols adhered to
National Institutes of Health Animal Care guidelines and were approved by the
Pennsylvania State University Institutional Animal Care and Use Committee.
Benserazide hydrochloride was dissolved in distilled water and administered at a
dose of 10 mg/kg 30 min before treatment with L-DOPA to inhibit peripheral dec-
arboxylation of L-DOPA. L-DOPA was dissolved in 0.1 M HCl and administered at
50 mg/kg. Reserpine was dissolved in 20-mL glacial acetic acid and then diluted to
volume with distilled water and administered at 20 mg/kg. (1)-Amphetamine was
dissolved in distilled water and injected at as dose of 10 mg/kg. Drug doses were
calculated as the free base and were administered intraperitoneally (i.p.) in a 0.2-mL
volume. Time periods prior to sacrifice were either 0.5 h or 2 h for L-DOPA, 6 h or
12 h for reserpine, and 1 h for amphetamine. Mice were euthanized by cervical
dislocation and brains were rapidly removed and dissected over ice to isolate the
bilateral striatal samples. All animals were sacrificed during the light portion of the
light/dark cycle.
Microfluidic device fabrication for the electrochemical cytometry of individual
vesicles. A hybrid capillary-microfluidic device was developed as previously
described to investigate transmitter amounts from individual isolated vesicles2,3.
Briefly, microfluidic channels were fabricated using conventional photo- and soft-
lithography methods. A master mold was developed by spin-coating 125 mm of SU-8
100 negative photoresist (MicroChem Corp., Newton, MA) on a 3-inch silicon wafer
(Silicon Quest International, Inc., Santa Clara, CA). A photolithographic mask was
placed over the wafer, exposed to ultraviolet light, and developed according to the
resist manufacturer protocol. Soft lithography was carried out using a SylgardH 184
silicone elastomer kit (Dow Corning Corp., Midland, MI). A 1051 ratio of
poly(dimethylsiloxane) (PDMS) prepolymer base to curing agent was cast onto the
master mold and cured at 70uC for 2 h. The PDMS layer was then peeled from the
master, revealing an impression of microfluidic channels. The center channel secured
the separation capillary and the other two channels, each 200-mm wide, were set at a
30u angle to the center channel and used to direct lysis buffer to the capillary outlet in a
sheath-flow format. The three channels converge into a 2-mm channel where the
electrode was placed for detection of catecholamine quantified from individual lysed
vesicles. A buffer reservoir for capillary electrophoresis was cut into a 2-mm layer of
PDMS and plasma-bonded to a glass micro slide (Corning Inc., Corning, NY). The
layer containing imprinted microfluidic channels was then plasma-bonded onto the
reservoir layer to assemble the device (100 W, 1 min).
Separation and detection of isolated vesicles. Fused-silica capillaries (45 cm in
length, 15-mm i.d./150-mm o.d., Polymicro Technologies, Phoenix, AZ) were
prepared for electrochemical detection by removing 2 mm of the polyimide coating
with a flame and subsequently etching the exposed fused silica by purging He
(250 psi) for 15 min in an HF bath. This resulted in an etch with a frustum geometry
measuring approximately 40-mm wide at the base, which served to both ease
placement of the electrode at the capillary outlet, as well as to decouple the applied
separation voltage from the electrochemical cell36. Electrokinetic injections of vesicles
were performed for 5 s at 111 V/cm and separations were carried out at 333 V/cm
using a high voltage supply (Spellman,Hauppauge, NY). Capillaries were conditioned
before each separation to prevent nonspecific binding of the vesicle membrane to the
fused-silica by rinsing at 333 V/cm with 1 MNaOH for 2 min, UltratrolTM Dynamic
Pre-Coat-HN (Target Discovery, Palo Alto, CA) for 5 min, and separation buffer for
10 min. A syringe pump (KD Scientific, Holliston, MA) was used to control
volumetric flow of lysis buffer via 1-mL plastic syringes continuously through the
microchannels at a rate of 2 mL/min (0.05 cm/s). Amperometric electrochemical
detection was carried out in a two-electrode format. A 5-mm-diameter carbon fiber
was sealed in a glass capillary and cut to a length of approximately 50 mm from the
glass seal to fabricate a cylindrical microelectrode as previously described37. The
electrode was held at 0.90 V versus a silver wire quasi reference electrode (Ag QRE,
0.25-mm-diameter, Alfa Aesar, Ward Hill, MA) and the carbon-fiber electrode was
positioned at the outlet of the capillary using a micromanipulator (Newport, Irvine,
CA). Previous measurements and modeling indicate that this system provides a
coulometric efficiency .95%2. Current was measured using a Keithly model 427
(15 Hz bandpass) current amplifier (Cleveland, OH) and digitized at 5000 Hz with a
National Instruments PCI-6221 DAQ card using LabView 8.0 software (National
Instruments, Austin, TX) written in-house. OriginLab 8.0 (Northampton, MA) was
used to generate electropherograms and Mini Analysis (Synaptosoft Inc., Fort Lee,
NJ) was used for peak identification and subsequent integration. Events were
quantified if the signal exceeded a threshold greater than three times the RMS baseline
noise.
Western blot of isolated vesicles. Vesicles isolated from brain tissue were
investigated for the presence of synaptophysin, a known integral membrane protein
present in synaptic and neuroendocrine vesicles. A 50-mL suspension of vesicles was
combinedwith 50 mL of lysis solution containing 5% (w/v) SDS in 50 mMTES buffer.
The mixture was vortexed vigorously for 1 min. Aliquots of this solution containing
,20 mg of protein were loaded into four lanes of a 12% SDS-PAGE gel. Separations
were carried out by applying a 200 V potential for 2 h. A SeeBlueH Plus2 pre-stained
standard protein kit (Invitrogen, Carlsbad, CA) was used to visualize the separation.
The gel was then transferred onto nitrocellulose paper, followed by blocking and
incubation with the primary antibody monoclonal anti-synaptophysin (2-h
incubation at room temperature; 151000 dilution of antibody. Monoclonal anti-
synaptophysin antibody was provided in the Synaptic Vesicle Isolation Kit). The
secondary antibody, HRP-conjugated anti-mouse IgG, was used for
chemiluminescent detection of the targeted protein (ProteoQwest
ChemiluminescentWestern Blotting Kit, Sigma Aldrich). Results revealed a
prominent band at 38 kDa, confirming the presence of synaptophysin in the vesicle
lysate.
Statistical analysis.Histograms of vesicular neurotransmitter amounts are plotted as
a function of vesicle volume, as the cubed root transforms of these amounts
approximate normal distributions of the data10. Fits of histogramswere obtained from
Gaussian distributions of the data. The number of events recorded (or vesicles
measured) were counted as theN value for hypothesis testing. Data in Figure 2C were
analyzed by ANOVA of the means. The means of the data in Figure 2B and Figure 3
possessed unequal variances and, therefore, were analyzed by a two-tailed unpaired
Student’s t-test.
1. Staal, R. G. W., Mosharov, E. V. & Sulzer, D. Dopamine neurons release
transmitter via a flickering fusion pore. Nat Neurosci. 7, 341–346 (2004).
2. Omiatek, D. M., Santillo, M. F., Heien, M. L. & Ewing, A. G. Hybrid capillary-
microfluidic device for the separation, lysis, and electrochemical detection of
vesicles. Anal Chem. 81, 2294–2302 (2009).
3. Omiatek, D. M., Dong, Y., Heien, M. L. & Ewing, A. G. Only a fraction of quantal
content is released during exocytosis as revealed by electrochemical cytometry of
secretory vesicles. ACS Chem Neurosci. 1, 234–245 (2010).
4. Zhou, Z. &Misler, S. Amperometric detection of stimulus-induced quantal release
of catecholamines from cultured superior cervical-ganglion neurons. Proc Natl
Acad Sci USA. 92, 6938–6942 (1995).
5. Pothos, E. N., Davila, V. & Sulzer, D. Presynaptic recording of quanta from
midbrain dopamine neurons and modulation of the quantal size. J Neurosci. 18,
4106–4118 (1998).
6. Hochstetler, S. E., Puopolo, M., Gustincich, S., Raviola, E. & Wightman, R. M.
Real-time amperometric measurements of zeptomole quantities of dopamine
released from neurons. Anal Chem. 72, 489–496 (2000).
7. Geiger, B. M. et al. Evidence for defective mesolimbic dopamine exocytosis in
obesity-prone rats. FASEB J. 22, 2740–2746 (2008).
8. Chiu, D. T. et al. Probing single secretory vesicles with capillary electrophoresis.
Science. 279, 1190–1193 (1998).
9. Fuller, K. M. & Arriaga, E. A. Analysis of individual acidic organelles by capillary
electrophoresis with laser-induced fluorescence detection facilitated by the
endocytosis of fluorescently labeled microspheres. Anal Chem. 75, 2123–2130
(2003).
www.nature.com/scientificreports
SCIENTIFIC REPORTS | 3 : 1447 | DOI: 10.1038/srep01447 5
10. Finnegan, J. M. et al. Vesicular quantal size measured by amperometry at
chromaffin, mast, pheochromocytoma, and pancreatic beta-cells. J Neurochem.
66, 1914–1923 (1996).
11. Cragg, S., Rice, M. E. & Greenfield, S. A. Heterogeneity of electrically evoked
dopamine release and reuptake in substantia nigra, ventral tegmental area, and
striatum. J Neurophysiol. 77, 863–873 (1997).
12. Rice, M. E., Cragg, S. J. & Greenfield, S. A. Characteristics of electrically evoked
somatodendritic dopamine release in substantia nigra and ventral tegmental area
in vitro. J Neurophysiol. 77, 853–862 (1997).
13. Andrews, A.M. &Murphy, D. L. 29-NH2-MPTP in SwissWebster mice: Evidence
for long-term (6-month) depletions in cortical and hippocampal serotonin and
norepinephrine, differential protection by selective uptake inhibitors or clorgyline
and functional changes in central serotonin neurotransmission. J Pharmacol Exp
Ther. 267, 1432–1439 (1993).
14. Kozminski, K. D. et al. Voltammetric and pharmacological characterization of
dopamine released from single quantal events in PC12 cells. Anal. Chem. 70,
3123–3130 (1998).
15. Colliver, T. L., Pyott, S. J., Achalabun, M. & Ewing, A. G. VMAT-mediated
changes in quantal size and vesicular volume. J. Neurosci. 20, 5276–5282 (2000).
16. Pothos, E. N. et al. Synaptic Vesicle Transporter Expression Regulates Vesicle
Phenotype and Quantal Size. J. Neurosci. 20, 7297–7306 (2000).
17. Schmitz, Y., Benoit-Marand, M., Gonon, F. & Sulzer, D. Presynaptic regulation of
dopaminergic neurotransmission. J. Neurochem. 87, 273–289 (2003).
18. Graybiel, A. M., Aosaki, T., Flaherty, A. W. & Kimura, M. The basal ganglia and
adaptive motor control. Science. 265, 1826–1831 (1994).
19. Pickel, V. M., Beckley, S. C., Joh, T. H. & Reis, D. J. Ultrastructural
immunocytochemical localization of tyrosine hydroxylase in the neostriatum.
Brain Res. 225, 373–385 (1981).
20. Garris, P. A., Ciolkowski, E. L., Pastore, P. &Wightman, R.M. Efflux of dopamine
from the synaptic cleft in the nucleus-accumbens of the rat brain. J Neurosci. 14,
6084–6093 (1994).
21. Pothos, E. N. Regulation of dopamine quantal size in midbrain and hippocampal
neurons. Behav Brain Res. 130, 203–207 (2002).
22. Jaffe, E. H., Marty, A., Schulte, A. & Chow, R. H. Extrasynaptic vesicular
transmitter release from the somata of substantia nigra neurons in rat midbrain
slices. J Neurosci. 18, 3548–3553 (1998).
23. Benzekhroufa, K. et al. Adenoviral vectors for highly selective gene expression in
central serotonergic neurons reveal quantal characteristics of serotonin release in
the rat brain. BMC Biotechnology 9, 23 (2009).
24. Cans, A. S. et al. Measurement of the dynamics of exocytosis and vesicle retrieval
at cell populations using a quartz crystalmicrobalance.Anal Chem. 73, 5805–5811
(2001).
25. Montesinos, M. S. et al. The crucial role of chromogranins in storage and
exocytosis revealed using chromaffin cells from chromogranin A null mouse.
J Neurosci. 28, 3350–3358 (2008).
26. Amatore, C., Oleinick, A. I. & Svir, I. Reconstruction of Aperture Functions during
Full Fusion in Vesicular Exocytosis of Neurotransmitters. Chemphyschem. 11,
159–174 (2010).
27. Mellander, L. J., Trouillon, R., Svensson, M. I. & Ewing, A. G. Amperometric post
spike feet reveal most exocytosis is via extended kiss-and-run fusion. Scientific
Reports 2, 907 (2012).
28. Blessing, H., Bareiss, M., Zettlmeisl, H., Schwarz, J. & Storch, A. Catechol-O-
methyltransferase inhibition protects against 3,4-dihydroxyphenylalanine
(DOPA) toxicity in primary mesencephalic cultures: new insights into levodopa
toxicity. Neurochem Int. 42, 139–151 (2003).
29. Mena, M. A., Casarejos, M. J., Solano, R. M. & de Yebenes, J. G. Half a Century of
L-DOPA. Curr Top Med Chem. 9, 880–893 (2009).
30. Mosharov, E. V. et al. Interplay between cytosolic dopamine, calcium, and alpha-
synuclein causes selective death of substantia nigra neurons.Neuron. 62, 218–229
(2009).
31. Lipski, J. L-DOPA: A scapegoat for accelerated neurodegeneration in Parkinson’s
disease? Prog Neurobiol. 94, 389–407 (2011).
32. Sulzer, D. et al. Amphetamine redistributes dopamine from synaptic vesicles to
the cytosol and promotes reverse transport. J Neurosci. 15, 4102–4108 (1995).
33. Jones, S. R., Gainetdinov, R. R., Wightman, R. M. & Caron, M. G. Mechanisms of
amphetamine action revealed in mice lacking the dopamine transporter.
J Neurosci. 18, 1979–1986 (1998).
34. Sulzer, D. & Rayport, S. Amphetamine and Other Psychostimulants Reduce Ph
Gradients in Midbrain Dopaminergic-Neurons and Chromaffin Granules - a
Mechanism of Action. Neuron. 5, 797–808 (1990).
35. Hondebrink, L., Meulenbelt, J., Timmerman, J. G., van den Berg, M. &Westerink,
R. H. S. Amphetamine reduces vesicular dopamine content in dexamethasone-
differentiated PC12 cells only following L-DOPA exposure. J Neurochem. 111,
624–633 (2009).
36. Powell, P. R., Woods, L. A. & Ewing, A. G. Characterization of etched
electrochemical detection for electrophoresis inmicron inner diameter capillaries.
J Sep Sci. 28, 2540–2545 (2005).
37. Kawagoe, K. T., Zimmerman, J. B. &Wightman, R. M. Principles of voltammetry
and microelectrode surface-states. J Neurosci Meth. 48, 225–240 (1993).
Acknowledgements
We acknowledge the European Research Council (Advanced Grant), Knut and Alice
Wallenberg Foundation, the Swedish Research Council (VR) for financial support.
Author contributions
D.M.O. contributed to the experimental design, collected and analyzed data, interpreted the
data and models and wrote the first drafts of the manuscript. A.J.B. worked with the mice
and carried out in vivo experimental aspects, helped analyze data and edit the manuscript.
A.S.C. interpreted experimental results and edited parts of themanuscript. A.M.A. provided
expertise in pharmacology, mouse experimental protocols, edited the manuscript and
interpreted data. M.L.H. aided in experimental design for cytometry, interpretation of data,
and writing the manuscript. A.G.E. participated in design and interpretation of the
experiments, writing of the manuscript, and acquired the resources and environment for
the work to be done.
Additional information
Competing financial interests: The authors declare no competing financial interests.
License: This work is licensed under a Creative Commons
Attribution-NonCommercial-NoDerivs 3.0 Unported License. To view a copy of this
license, visit http://creativecommons.org/licenses/by-nc-nd/3.0/
How to cite this article: Omiatek, D.M. et al. The real catecholamine content of secretory
vesicles in the CNS revealed by electrochemical cytometry. Sci. Rep. 3, 1447; DOI:10.1038/
srep01447 (2013).
www.nature.com/scientificreports
SCIENTIFIC REPORTS | 3 : 1447 | DOI: 10.1038/srep01447 6
